Tylenol Recall Update

Since the April recall, Children's Tylenol, Benadryl, Motrin and other McNeil Pharmaceutical products are still unavailable for purchase. The latest report says we should not expect a return of these products until 2011. You can receive updates from the makers of Tylenol on their website. -Jay Gordan, MD

Mental Attitude: Smile! It takes only 17 muscles to smile versues 43 to frown. So put on a winning smile. -Gray's Anatomy

Mental Attitude: Smile! It takes only 17 muscles to smile versues 43 to frown. So put on a winning smile. -Gray's Anatomy

Pharmaceutical companies are expected to increase profits 3-6 percent annually in the next 5 years.

In 2014 they could reach $360-$390 Billion, which would be up from $300 Billion in 2009.

Insight into recent settlements.

-U.S. Department of Justice announced (April, 2010) that AstraZeneca had agreed to pay $520 Million to settle a claim it fraudulently marketed the anti psychotic drug Seroquel.

- October 2009, Pfizer, Inc., was fined $2.3 Billion for similar off-label marketing practices, as well as illegal marketing activities including vacations and other perks to doctors as incentives to prescribe.

-January 2010, McNeil, a division of Johnson n Johnson issued a recall of Motrin, Tylenol and Benadryl because of a musty, moldy or mildew-like odor that made people sick. April 2010, a second recall was done for infant/child fever reducers and allergy medications. In a statement, "Some of these products included in the recall may contain higher concentrations of active ingredients than is specified, ..." The FDA is considering fines.

(June 3, 2010 Dynamic Chiropractic).

Interested in a Career as a Chiropractor?

Thursday May 27th at 7:30 at our office, join Drs. Tanya Reynolds and Michael Karr for a discussion about a career as a chiropractor.-Together with Life Chiropractic College

Chiropractic More Effective Than “Usual Care” For Back Pain
| Filed Under Back Pain, Chiropractic Studies |

A recent article in Lippincott’s Bone and Joint Newsletter published an article on the effectiveness of chiropractic for acute back pain. The article discusses the work of Dr. Paul Bishop, DC, PhD, MD, a professor of orthopedics at the University of British Columbia.

The work presented by Dr. Bishop at the International Society for the Study of the Lumbar Spine in Hong Kong states:

“This is the first randomized controlled trial demonstrating that full clinical practice guidelines care including chiropractic spinal manipulative therapy produces more favorable patient outcomes than family physician-directed care in acute low back pain patients.”

Bishop and his colleagues studied 88 patients with acute back pain. The patients were assigned to either a “guidelines-based” chiropractic group or a “usual care” group by family physicians.

“The guidelines-based care included reassurance, avoidance of passive treatments, acetaminophen for pain control, four weeks of twice-weekly spinal manipulation, and return-to-work within eight weeks.”

The outcome measure used was the Roland Morris Questionnaire, and the authors found that the chiropractic patients experienced a significantly greater improvement (2.52 points on the Roland Morris) compared to the “usual care” group (.25 on the Roland Morris).

The authors reported that “usual care” treatment offered by most primary care physicians was not based on the science of back pain (it was, in Bishop’s words, “highly guideline-discordant).

“Typically, the family physician-based care involved excessive use of passive therapies such as massage and passive physical therapy, excessive bed rest, and excessive use of narcotic analgesics, Bishop added.”